Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Aromatase inhibitors cause male pattern hair loss in women.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Including androgens in hormone therapy may lower breast cancer risk.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Estrogen therapy can reduce skin aging but has cancer risks.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.